Research Article
Does Obesity Predispose Medical Intensive Care Unit Patients to Venous Thromboembolism despite Prophylaxis? A Retrospective Chart Review
Table 4
Characteristics of VTE patients.
| | Characteristics | BMI < 30 kg/m2 | BMI ≥ 30 kg/m2 | | |
| | BMI of patients with VTE (SD) | 25.7 (3.23) | 39.3 (9.7) | | Less than or equal to 20 | 1 | 0 | | 20.1–25 | 3 | 0 | | 25.1–29.9 | 8 | 0 | | 30–34.9 | 0 | 9 | | 35–39.9 | 0 | 3 | | Greater than or equal to 40 | 0 | 6 | | Male (%) | 6 (50%) | 7 (39%) | | Age (SD) | 61.5 (15.4) | 63 (15.1) | | Primary admission Dx | | | | Cardiovascular | 0 | 3 | | Respiratory | 8 | 8 | | Gastrointestinal | 0 | 3 | | Renal | 1 | 1 | | Neurologic | 1 | 0 | | Sepsis | 2 | 3 | | Other | 0 | 0 | | Secondary admission Dx | | | | Cardiovascular | 0 | 1 | | Respiratory | 2 | 2 | | Gastrointestinal | 0 | 2 | | Renal | 1 | 1 | | Neurologic | 0 | 0 | | Sepsis | 3 | 2 | | Other | 1 | 0 | | APS, 1 hour (SD) | 42 (31.5) | 39.2 (19.3) | | APS, 24 hours (SD) | 70.5 (17.6) | 68.4 (24.2) | | On vasopressor anytime | 10 | 12 | | Vasopressor at time of event | 2 | 3 | | Norepinephrine | 1 | 3 | | Vasopressin | | 0 | | Epinephrine | 0 | 0 | | Phenylephrine | | 0 | | Dopamine | 0 | 0 | | Dobutamine | 0 | 0 | | Antiplatelet agent | 3 | 6 | | Prior thrombosis | 2 | 2 | | Sleep apnea | 1 | 5 | | Active oncologic/hematologic malignancy | 3 | 9 | | Noninvasive ventilation at any time prior to event | 5 | 9 | | Noninvasive ventilation at time of event | 0 | 2 | | Invasive ventilation at any time prior to event | 10 | 13 | | Invasive ventilation at time of event | 8 | 8 | | Dialysis | | | | Acute/new | 3 | 6 | | Chronic | 0 | 0 | | IVC filter | 1 | 3 | | Mechanical VTE prophylaxis documented | 7 | 7 | | HIT | 2 | 2 |
|
|
patient on all vasopressors.
|
